The optimal mode of coronary revascularization for diabetics. A risk-adjusted long-term study comparing coronary angioplasty and coronary bypass surgery

European Heart Journal

Volumn 19, Issue 11, 1998, Pages 1696-1703

  O'Keefe Jr , James H ^a,d   Blackstone, E H ^b   Sergeant, P ^c   McCallister, B D ^a  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b Kentucky   (United States)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d NONE   (United States)

Author keywords

Angioplasty; Coronary bypass surgery; Coronary disease; Diabetes; Outcomes

Indexed keywords

INSULIN;

ADULT; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; DATA BASE; DIABETES MELLITUS; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0032213408     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.1153     Document Type: Article

References (32)

1. [1] NHANES surveys. Update: prevalence of overweight among children, adolescents, and adults - United States, 1988-1994. MMWR 1997; 46: 198-202.
2. [2] Consensus statement. Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. American Diabetes Association Diabetes Care 1993; 16 (Suppl): 72-8.
3. [3] Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Curier JW. Coronary angioplasty in diabetic patients: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1996; 94: 1818-25.
4. [4] Stein B, Weintraub WAS, Gebhart SSP et al. Influence of diabetes mellitus on early and late outcome after percutaneous transmural coronary angioplasty. Circulation 1995; 91: 979-89.
5. [5] Stephan WJ, O'Keefe JH, Piehler JM et al. Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery. J Am Coll Cardiol 1996; 28: 1140-6.
6. [6] Barzilay JI, Kronmal RA, Bittner V, Eaker E, Evans C, Foster ED. Coronary artery disease and coronary artery bypass grafting in diabetic patients aged ≥65 years (report from the Coronary Artery Surgery Study (CASS) Registry). Am J Cardiol 1994; 74: 334-9.
7. [7] The Bypass Angioplasty Revascularization Investigation (BARI). Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease. Circulation 1997; 96: 1761-9.
8. [8] King SB, Lembo NJ, Weintraub WAS et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med 1994; 1044-50.
9. [9] Sergeant P, Blackstone E, Meyns B, and the KU Leuven Coronary Surgery Program. Identification, validation and interdependence with patient-variables of the influence of procedural variables on early and late survival after CABG. Eur J Cardio Thorac Surg 1997; 12: 1-19.
10. [10] O'Keefe JH, Blackstone EH, McCallister BD, Kirklin JW. Determinants of long-term survival after coronary angioplasty using the Hazard Function. Circulation 1996; 94: 1-507.
11. [11] O'Keefe JH, McCallister BD, Blackstone EH, Kirklin JW. The effects of diabetes and renal function on long-term outcome after coronary angioplasty. Circulation 1996; 94: 1-717.
12. [12] Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assn 1958; 53: 487-51.
13. [13] Blackstone EH, Naftel DC, Turner Jr ME. The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assn 1986; 81: 615-24.
14. [14] Bakerville JC, Toogood JH. Guided regressions modeling for prediction and exploration of structure with many explanatory variables. Technometrics 1982; 24: 9-17.
15. [15] Sergeant P, Blackstone E, Meyns B. Can the outcome of coronary bypass grafting be predicted reliable. Eur J Cardio Thor Surg 1997; 11: 2-9.
16. [16] University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VI. Supplementary report on non-fatal events in patients treated with tolbutamide. Diabetes 1970; 25: 1129-53.
17. [17] Abraira C, Colwell J, Nuttall F et al. Cardiovascular events and correlates in the Veteran Affairs Diabetes Feasibility Trial. Archives of Int Med 1997; 157: 181-8.
18. [18] Pogatsa G. Potassium channels in the cardiovascular system. Diabetes Res Clin Pract 1995; 28 (Suppl): S91-S98.
19. [19] Smits P, Thien T. Cardiovascular effects of sulfonylurea derivatives. Implications for the treatment of NIDDM. Diabetologia 1995; 38: 116-21.
20. [20] Baker JE, Curry BD, Olinger GN, Gross GJ. Increased tolerance of the chronically hypoxic immature heart to ischemia. Circulation 1995; 1278-85.
21. [21] Leibowitz G, Cerasi E. Sulfonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing? Diabetiologia 1996; 39: 503-14.
22. [22] O'Keefe JH, Allan JJ, McCallister BD et al. Angioplasty versus bypass surgery for multivessel coronary artery disease with left ventricular ejection fraction ≤40%. Am J Cardiol 1993; 71: 897-901.
23. [23] O'Keefe JH, Sutton MB, McCallister BD et al. Coronary angioplasty versus bypass surgery in patients >70 years old matched for ventricular function. J Am Coll Cardiol 1994; 24: 425-30.
24. [24] Hasdai D, Garratt KN, Grill DE, Lerman A, Holmes DR. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med 1997; 336: 755-61.
25. [25] Kahn JK, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Hartzler GO. Short and long-term results of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J 1990; 119: 484-9.
26. [26] The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration Randomized Trial of Coronary Bypass Surgery for Stable Angina. N Engl J Med 1984; 311: 1333-9.
27. [27] European Coronary Surgery Study Group. Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. Lancet 1982; 2: 1173-80.
28. [28] CASS Principal Investigators and their associates. Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery: survival data. Circulation 1983; 68: 939-50.
29. [29] Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996; 335: 217-25.
30. [30] Kornowski R, Mintz GS, Kent KM et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. Circulation 1997; 95: 1366-9.
31. [31] Aronson D, Bloomgarden Z, Rayfield EJ. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol 1996; 27: 528-35.
32. [32] Belle EB, Bauters C, Hubert E et al. Restenosis rates in diabetic patients. A comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 1997; 96: 1454-60.